September
7
TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases
Study to evaluate the delivery of SD-101, an investigational TLR9 agonist, in combination with...